Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | LIG1 | P18858 | 1/20 | 0.67 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | PARP1 | P09874 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669636 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL1131998 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL1426602 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL7068224 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL18259145 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL1889645 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL10542058 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| Zinc Ion SCHEMBL2788244 | 0.86 | LIG1 (0.67) | KDM4ELIG1CASP1CYP3A4MEN1 | |
| SCHEMBL9696302 | 0.86 | LIG1 (0.71) | KDM4ELIG1CYP3A4MEN1KMT2A | |
| SCHEMBL3435885 | 0.85 | KDM4E (0.54) | KDM4ELIG1CASP1CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010017328-A2 | CYCLODEXTRIN CONJUGATES | RGO BIOSCIENCES LLC (US) | 2010-02-11 | — | — | WO | claimed |
| US-6720124-B2 | USED IN CONNECTION WITH ORGANIC DYES HAVING EXCELLENT IMAGE FASTNESS, INK, COLOR FILTERS, HOLOGRAMS, PROOFS, SEALANTS, ADHESIVES, PLANOGRAPHY, RESIN LETTERPRESS, PHOTORESISTS AND THE LIKE | FUJI PHOTO FILM CO., LTD. (JP) | 2004-04-13 | — | — | US | claimed |
| US-20030073025-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2003-04-17 | — | — | US | claimed |
| JP-61172153-A | — | — | None | — | — | JP | disclosed |
| JP-61160763-A | — | — | None | — | — | JP | disclosed |
| JP-4282644-A | — | — | None | — | — | JP | disclosed |
| EP-4340807-A1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | Lubrizol Advanced Materials, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| US-11116710-B2 | Antimicrobial compositions | SYMRISE AG (DE) | 2021-09-14 | — | — | US | disclosed |
| EP-3773458-A1 | HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR | Lubrizol Advanced Materials, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019200027-A1 | HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2019-10-17 | — | — | WO | disclosed |
| US-20190282478-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2019-09-19 | — | — | US | disclosed |
| US-20030073025-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2003-04-17 | — | — | US | disclosed |
| EP-1262828-A1 | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2002-12-04 | — | — | EP | disclosed |
| JP-H04282644-A | IMAGE FORMING METHOD | RICOH CO LTD | 1992-10-07 | — | — | JP | disclosed |
| US-5106843-A | Treatment of migraine, emesis, anxiety, gastrointestinal disorders, psychological disorders | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| EP-0323077-B1 | HETEROCYCLIC COMPOUNDS | JOHN WYETH & BROTHER LIMITED (GB) | 1991-09-11 | — | — | EP | disclosed |
| US-4983600-A | Antiemetics, antianxiety agents, gastrointestinal disorders | JOHN WYETH & BROTHER LIMITED (GB) | 1991-01-08 | — | — | US | disclosed |
| EP-0323077-A1 | Heterocyclic compounds | JOHN WYETH & BROTHER LIMITED (GB) | 1989-07-05 | — | — | EP | disclosed |
| JP-S61172153-A | TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE | CANON INC | 1986-08-02 | — | — | JP | disclosed |
| JP-S61160763-A | ELECTROSTATIC CHARGE APPLYING MEMBER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE | CANON INC | 1986-07-21 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190282478-A1 | ANTIMICROBIAL COMPOSITIONS | MPO, NHERF1, NOX1 | KDM4E 2409/4885LIG1 3966/4885CASP1 827/4885 |
| US-11116710-B2 | Antimicrobial compositions | MPO, NHERF1, NOX1 | KDM4E 2598/4885LIG1 3988/4885CASP1 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.